O
DGX icon

Ossiam’s Quest Diagnostics DGX Stock Holding History

Ossiam’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Buy
3,332
+236
+8% +$46.3K 0.01% 465
2026
Q1 		$607K Buy
3,096
+673
+28% +$131K 0.01% 273
2025
Q4 		$420K Buy
2,423
+1,364
+129% +$248K 0.01% 296
2025
Q3 		$202K Buy
1,059
+61
+6% +$10.8K ﹤0.01% 607
2025
Q2 		$179K Buy
998
+316
+46% +$54.9K ﹤0.01% 548
2025
Q1 		$115K Buy
+682
New +$112K ﹤0.01% 544
2024
Q4 		– Sell
-202
Closed -$31.4K – 634
2024
Q3 		$31.4K Buy
+202
New +$30.2K ﹤0.01% 594
2024
Q1 		– Sell
-452
Closed -$62.3K – 643
2023
Q4 		$62.3K Hold
452
– – ﹤0.01% 635
2023
Q3 		$55.1K Sell
452
-1,171
-72% -$156K ﹤0.01% 653
2023
Q2 		$228K Buy
1,623
+355
+28% +$48.9K ﹤0.01% 595
2023
Q1 		$179K Sell
1,268
-4,207
-77% -$602K ﹤0.01% 497
2022
Q4 		$857K Buy
5,475
+312
+6% +$44.8K 0.02% 287
2022
Q3 		$633K Buy
5,163
+2,679
+108% +$353K 0.02% 341
2022
Q2 		$330K Sell
2,484
-8,814
-78% -$1.2M 0.01% 352
2022
Q1 		$1.55M Buy
+11,298
New +$1.57M 0.04% 194
2021
Q4 		– Sell
-1,072
Closed -$156K – 446
2021
Q3 		$156K Hold
1,072
– – ﹤0.01% 387
2021
Q2 		$152K Sell
1,072
-1,929
-64% -$253K ﹤0.01% 386
2021
Q1 		$385K Sell
3,001
-4,461
-60% -$550K 0.01% 310
2020
Q4 		$889K Buy
7,462
+2,897
+63% +$353K 0.03% 196
2020
Q3 		$523K Buy
4,565
+257
+6% +$30.4K 0.02% 245
2020
Q2 		$491K Sell
4,308
-17,120
-80% -$1.82M 0.03% 224
2020
Q1 		$1.72M Buy
21,428
+17,461
+440% +$1.81M 0.12% 128
2019
Q4 		$424K Sell
3,967
-541
-12% -$56.4K 0.03% 256
2019
Q3 		$482K Buy
4,508
+1,076
+31% +$110K 0.03% 236
2019
Q2 		$349K Buy
+3,432
New +$330K 0.03% 263

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Ossiam's DGX Position: Q2 2026 in Review

Ossiam increased its Quest Diagnostics (DGX) stake by 7.6% in Q2 2026, buying an estimated $46.3K and bringing the position to 3,332 shares worth $706K. The position accounts for 0.01% of the portfolio, ranked #465.

Ossiam first reported a position in DGX in Q2 2019 and has held it in 25 quarters since. The position peaked at $1.72M in Q1 2020. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Ossiam held 3,332 shares of Quest Diagnostics worth $706K as of Q2 2026.
  • Ossiam bought 236 Quest Diagnostics shares in Q2 2026, an estimated $46.3K.
  • Quest Diagnostics made up 0.01% of Ossiam's portfolio in Q2 2026, its #465 holding.
  • Ossiam first reported a position in Quest Diagnostics in Q2 2019 and has held it in 25 quarters since.
  • Ossiam's Quest Diagnostics position peaked at $1.72M in Q1 2020.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.